Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pseudoephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fenoldopam (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethylnorepinephrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levosalbutamol |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isometheptene mucate |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephryl borate |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylpropylmethylamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mephentermine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lergotrile (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bromocriptine mesilate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoproterenol sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etafedrine (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Racephedrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclopentamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Protokylol (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amantadine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoetharine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apomorphine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylaminoheptane |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caramiphen hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etilefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norfenefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cathine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylephedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorprenaline |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octopamine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
synéphrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pholedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxymetazoline hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lisuride maleate (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Midodrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with alpha adrenergic receptor agonist mechanism of action (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with central alpha adrenergic receptor agonist mechanism of action |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dipivefrine (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
vasoconstricteur |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pseudoephedrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with beta adrenergic receptor agonist mechanism of action (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alpha-2 adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Noradrenaline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sympathomimetic identification |
Component |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dopaminergic drugs (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sympathomimetic poisoning NOS |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental adrenalin poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional adrenalin poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenalin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental norepinephrine poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional norepinephrine poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la norépinéphrine d'intention indéterminée |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sympathomimetic adverse reaction |
Causative agent (attribute) |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dopamine adverse reaction |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xamoterol adverse reaction |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sympathomimetic allergy |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to dipivefrin |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to dopamine |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to ephedrine (finding) |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to oxymetazoline |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to xamoterol |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sympathomimetic overdose (disorder) |
Causative agent (attribute) |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xamoterol fumarate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine + inotropics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 1mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:10,000 1mg/10mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1000micrograms/mL injection solution 0.3mL prefilled pen (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 150micrograms/0.3mL preloaded injection pen (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 5mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 100micrograms/mL injection solution 10mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1mg/mL injection solution 1mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:1000 5mg/5mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
chlorhydrate de dopamine 40 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
chlorhydrate de dopamine 160 mg/mL, ampoule de 5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
chlorhydrate de dopamine 40 mg/mL, seringue préremplie de 5 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine hydrochloride 400mg/10mL prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xamoterol [sympathomimetic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vasoconstrictor sympathomimetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
tartrate acide de norépinéphrine 2 mg/mL, ampoule de 20 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
tartrate acide de norépinéphrine de 2 mg/mL, ampoule de 2 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Noradrenaline acid tartrate 8mg/4mL infusion concentrate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxedrine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine [resp] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bronchilator inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bronchodilators + sedative |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Epinephrine 1:1000 1mg/mL topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by levarterenol |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.01% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline acid tartrate 0.1% preservative-free eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral adrenaline 0.1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neutral epinephrine 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline 1:10,000 300micrograms/3mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alpha adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Noradrenaline product (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline eye drops (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xamoterol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|